Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1986 1
1994 1
1998 1
1999 4
2000 3
2001 7
2002 3
2003 5
2004 1
2005 4
2006 9
2007 11
2008 10
2009 15
2010 26
2011 25
2012 34
2013 30
2014 24
2015 32
2016 41
2017 56
2018 54
2019 60
2020 58
2021 37
Text availability
Article attribute
Article type
Publication date

Search Results

482 results
Results by year
Filters applied: . Clear all
Page 1
Pembrolizumab for Early Triple-Negative Breast Cancer.
Schmid P, Cortes J, Pusztai L, McArthur H, Kümmel S, Bergh J, Denkert C, Park YH, Hui R, Harbeck N, Takahashi M, Foukakis T, Fasching PA, Cardoso F, Untch M, Jia L, Karantza V, Zhao J, Aktan G, Dent R, O'Shaughnessy J; KEYNOTE-522 Investigators. Schmid P, et al. N Engl J Med. 2020 Feb 27;382(9):810-821. doi: 10.1056/NEJMoa1910549. N Engl J Med. 2020. PMID: 32101663 Clinical Trial.
Phototherapy for Vitiligo: A Systematic Review and Meta-analysis.
Bae JM, Jung HM, Hong BY, Lee JH, Choi WJ, Lee JH, Kim GM. Bae JM, et al. Among authors: kim gm. JAMA Dermatol. 2017 Jul 1;153(7):666-674. doi: 10.1001/jamadermatol.2017.0002. JAMA Dermatol. 2017. PMID: 28355423 Free PMC article. Review.
Current Trends for Treating Lateral Epicondylitis.
Kim GM, Yoo SJ, Choi S, Park YG. Kim GM, et al. Clin Shoulder Elb. 2019 Dec 1;22(4):227-234. doi: 10.5397/cise.2019.22.4.227. eCollection 2019 Dec. Clin Shoulder Elb. 2019. PMID: 33330224 Free PMC article. Review.
Prediction of Early Recurrence After Acute Ischemic Stroke.
Arsava EM, Kim GM, Oliveira-Filho J, Gungor L, Noh HJ, Lordelo Mde J, Avery R, Maier IL, Ay H. Arsava EM, et al. Among authors: kim gm. JAMA Neurol. 2016 Apr;73(4):396-401. doi: 10.1001/jamaneurol.2015.4949. JAMA Neurol. 2016. PMID: 26926383
Palbociclib plus exemestane with gonadotropin-releasing hormone agonist versus capecitabine in premenopausal women with hormone receptor-positive, HER2-negative metastatic breast cancer (KCSG-BR15-10): a multicentre, open-label, randomised, phase 2 trial.
Park YH, Kim TY, Kim GM, Kang SY, Park IH, Kim JH, Lee KE, Ahn HK, Lee MH, Kim HJ, Kim HJ, Lee JI, Koh SJ, Kim JY, Lee KH, Sohn J, Kim SB, Ahn JS, Im YH, Jung KH, Im SA; Korean Cancer Study Group (KCSG). Park YH, et al. Among authors: kim gm. Lancet Oncol. 2019 Dec;20(12):1750-1759. doi: 10.1016/S1470-2045(19)30565-0. Epub 2019 Oct 24. Lancet Oncol. 2019. PMID: 31668850 Clinical Trial.
482 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page